2.53
-0.04(-1.56%)
Currency In USD
| Previous Close | 2.57 |
| Open | 2.54 |
| Day High | 2.56 |
| Day Low | 2.48 |
| 52-Week High | 14.2 |
| 52-Week Low | 2.11 |
| Volume | 76,606 |
| Average Volume | 157,052 |
| Market Cap | 37.07M |
| PE | 0.42 |
| EPS | 6 |
| Moving Average 50 Days | 3.16 |
| Moving Average 200 Days | 4.52 |
| Change | -0.04 |
If you invested $1000 in Veru Inc. (VERU) 10 years ago, it would be worth $174.48 as of December 12, 2025 at a share price of $2.53. Whereas If you bought $1000 worth of Veru Inc. (VERU) shares 5 years ago, it would be worth $26.08 as of December 12, 2025 at a share price of $2.53.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Veru to Report Fiscal Year 2025 Financial Results on December 17th
GlobeNewswire Inc.
Dec 10, 2025 1:30 PM GMT
MIAMI, FL, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it wil
Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop
GlobeNewswire Inc.
Dec 04, 2025 1:30 PM GMT
MIAMI, FL, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced multip
Veru to Present Two Abstracts at ObesityWeek 2025
GlobeNewswire Inc.
Oct 31, 2025 12:30 PM GMT
MIAMI, FL, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the pr